US Patent Issued to Neurocrine Biosciences on Dec. 2 for "Muscarinic receptor 4 antagonists and methods of use" (California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,250, issued on Dec. 2, was assigned to Neurocrine Biosciences Inc. (San Diego).

"Muscarinic receptor 4 antagonists and methods of use" was invented by Nicholas Pagano (San Diego), Nicole Harriott (San Diego), Brian M. Cochran (San Diego), Scott Stirn (San Diego) and Christina Marie Costa (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of the following Formula (I): or a pharmaceutically acceptable salt thereof. Methods for treating a diseases, disorders, or symptom by antagonizing muscarinic receptors, including specifically antagonizing muscarinic receptor 4 (M4), are also provided."

The patent was filed on De...